J. Treat

Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.

J. Treat, Eugene H. Johnson, Corey J. Langer et al. · Journal of Clinical Oncology · 1998 · 65 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of patient outcomes stratified by histology among pemetrexed (P)-treated patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC) in two phase II trials

G. Peng, Ralph Zinner, Y. Wang et al. · Journal of Clinical Oncology · 2008 · 17 citations

Medicine, Oncology, Pharmacology +16

Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)

Jyoti D. Patel, Thomas A. Hensing, F. Rademaker et al. · Journal of Clinical Oncology · 2008 · 14 citations

Medicine, Oncology, Pharmacology +11

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

J. Treat, Belani P. Chandra, Martin J. Edelman et al. · Lung Cancer · 2003 · 10 citations

Medicine, Oncology, Pharmacology +14